EGRP-Supported Epidemiology Consortia

Ovarian Cancer


Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)

Since 2009
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
ENIGMA Liaison:

Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

Lead Investigator:

David Goldgar, Ph.D.
University of Utah
gold@episun3.med.utah.edu

Ovarian Cancer Association Consortium (OCAC)

Since 2005
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
OCAC Liaison:

Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

Lead Investigator:

Andrew Berchuck, M.D.
Duke University Comprehensive Cancer Center
Berch001@mc.duke.edu

Ovarian Cancer Cohort Consortium (OC3)

Since 2009
NIH Contacts

EGRP/NCI:

OC3 Liaison:
Sheri Schully
schullys@mail.nih.gov

Scientific Consortia Coordinator:
Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

DCEG/NCI:

Nicolas Wentzensen, M.D., Ph.D.
wentzenn@mail.nih.gov

Lead Investigators:

Shelley Tworoger, Ph.D.
Harvard University School of Public Health
stworoge@hsph.harvard.edu

Alan Arslan, M.D.
New York University
alan.arslan@nyumc.org

Ovarian Cancer in Women of African Ancestry (OCWAA)

Since 2013
NIH Contacts

EGRP/NCI:

OCWAA Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.
Krista.Zanetti@nih.gov

Scientific Consortia Coordinator:
Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

Lead Investigators:

Patricia G. Moorman, Ph.D., M.S.P.H.
Duke Cancer Institute
moorm007@mc.duke.edu

Joellen M. Schildkraut, Ph.D., M.P.H.
Duke Cancer Institute
joellen.schildkraut@duke.edu

Pacific Ovarian Cancer Research Consortium (POCRC)

Since 1999
NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
POCRC Liaison:

Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

Lead Investigator:

Nicole Urban, Ph.D.
University of Washington School of Public Health
nurban@fhcrc.org

Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)

NIH Contacts

EGRP/NCI:

Scientific Consortia Coordinator &
PROSE Liaison:

Daniela Seminara, Ph.D., M.P.H.
seminard@mail.nih.gov

Consortia Fellow:
Eric DeRycke, M.P.H.
eric.derycke@nih.gov

Lead Investigators:

Timothy Rebbeck, Ph.D.
University of Pennsylvania
trebbeck@cceb.med.upenn.edu

Key to Acronyms Used in Tables
  • EGRP - Epidemiology and Genomics Research Program
  • CDC - Centers for Disease Control and Prevention
  • DCB - Division of Cancer Biology
  • DCEG - Division of Cancer Epidemiology and Genetics
  • NCI - National Cancer Institute
  • NHGRI - National Human Genome Research Institute
  • NIEHS - National Institute of Environmental Health Sciences
  • NIH - National Institutes of Health
  • OCS - Office of Cancer Survivorship
  • OD - Office of the Director

Return to Top